Should abdominal obesity be used as a risk predictor?
- Cardio
- 03/04/2018
A recent study by Tsujimoto and Kajio assessed the relationship between abdominal obesity and mortality among patients with heart failure and preserved
READ MOREA recent study by Tsujimoto and Kajio assessed the relationship between abdominal obesity and mortality among patients with heart failure and preserved
READ MOREResults of a randomised trial highlight the potential of smartphone applications to help clinicians make decisions at the bedside. In this study,...
READ MOREDespite multiple examples of glucose-lowering therapies affecting heart failure (HF) risk, ascertainment of HF data in cardiovascular (CV) outcome...
READ MOREPreliminary research indicates that depression may increase the risk for atrial fibrillation (AFib), the most common heart rhythm disorder that can...
READ MOREKaiser Permanente's integrated programme (PHASE), implemented between 2004-2013 in Northern California, has been effective in helping diabetes patients
READ MOREA multicentre study supports the value of a biomarker to accurately diagnose or rule out acute heart failure in patients seen for shortness of breath...
READ MOREType 2 diabetes mellitus (T2DM) is a complex disease with a pathogenesis that is multidimensional. Recently, several specific glucose-lowering agents...
READ MOREThe cardiac troponin blood test is the current gold standard test used for the clinical diagnosis of myocardial infarction (MI or death of heart...
READ MOREHeart patients who participate in cardiac rehabilitation programmes typically do well during enrolment but tend to revert to unhealthy lifestyles...
READ MORE